(Q53304052)

13 May 2018

title

Ten years later: A single hospital experience with malignancy in HIV/AIDS (English)

1 reference

23 June 2024

author name string

Mary Reed

1

1 reference

13 May 2018

Richard Cindrich

3

1 reference

13 May 2018

Youhanna Gad

5

1 reference

13 May 2018

Madan Bangalore

6

1 reference

13 May 2018

Robert Uzor

7

1 reference

13 May 2018

Jawaid Kalim

8

1 reference

13 May 2018

Raymundo Segura

9

1 reference

13 May 2018

Eugene Albu

10

1 reference

13 May 2018

John M. Cosgrove

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20740588

23 June 2024

Vellore S. Parithivel

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20740588

23 June 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20740588

23 June 2024

publication date

1 September 2010

1 reference

13 May 2018

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fjso.21590

1 reference

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jso.21590

23 June 2024

1 reference

Journal of Surgical Oncology

23 June 2024

published in

1 reference

13 May 2018

volume

102

1 reference

13 May 2018

issue

3

1 reference

13 May 2018

page(s)

282-286

1 reference

13 May 2018

The prevalence of hepatitis C virus infection in the United States, 1999 through 2002

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FJSO.21590

Malignancy in HIV/AIDs: a single hospital experience

21 January 2018

1

1 reference

Highly active antiretroviral therapy (HAART) improves survival in HIV-associated Hodgkin's disease: results of a multicenter study

23 June 2024

2

1 reference

Hodgkin lymphoma among patients infected with HIV in post-HAART era.

23 June 2024

4

1 reference

Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort study

23 June 2024

6

1 reference

Incidence and outcomes of malignancy in the HAART era in an urban cohort of HIV-infected individuals

23 June 2024

7

1 reference

British HIV Association guidelines for HIV-associated malignancies 2008

23 June 2024

8

1 reference

HIV infection in older adults

23 June 2024

9

1 reference

23 June 2024

10

1 reference

Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection.

23 June 2024

11

1 reference

Hepatitis C and B-cell lymphoma

23 June 2024

14

1 reference

Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus

23 June 2024

15

1 reference

Rituximab plus infusional cyclophosphamide, doxorubicin, and etoposide in HIV-associated non-Hodgkin lymphoma: pooled results from 3 phase 2 trials.

23 June 2024

16

1 reference

Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV-HCV International Panel.

23 June 2024

17

1 reference

Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy

23 June 2024

18

1 reference

HIV and aging: implications for patient management

23 June 2024

19

1 reference

Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals

23 June 2024

20

1 reference

Cirrhosis and hepatocellular carcinoma in HIV-infected veterans with and without the hepatitis C virus: a cohort study, 1992-2001.

23 June 2024

21

1 reference

Hepatitis C is more severe in drug users with human immunodeficiency virus infection

23 June 2024

22

1 reference

Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis

23 June 2024

23

1 reference

Hepatitis C virus infection as an opportunistic disease in persons infected with human immunodeficiency virus

23 June 2024

24

1 reference

Acquired immunodeficiency syndrome-related lymphoma: simultaneous treatment with combined cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy and highly active antiretroviral therapy is safe and improves survival--results of the

23 June 2024

25

1 reference

Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin's lymphoma

23 June 2024

26

1 reference

23 June 2024

Identifiers

DOI

10.1002/JSO.21590

1 reference

13 May 2018

1 reference

13 May 2018